1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        North America Branded Generics Market – By Therapeutic Application

1.3.2        North America Branded Generics Market – By Distribution Channel

1.3.3        North America Branded Generics Market – By Drug Class

1.3.4        North America Branded Generics Market – By Formulation Type

1.3.5        North America Branded Generics Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           North America Branded Generics Market – Market Landscape

4.1         Overview

4.2         North America PEST Analysis

4.3         Experts Opinion

5.           North America Branded Generics Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Increasing Penetration of Branded Generics

5.1.2        Surging Government Initiatives for Promoting Branded Generics

5.2         Market Restraints

5.2.1        Switching Brands, Poorer Clinical Outcomes and Adverse Effects of Generic Medications

5.3         Market Opportunities

5.3.1        Product Differentiation Creating Opportunities

5.4         Future Trends

5.4.1        Encouraging Utility of Branded Generics by Healthcare Providers and Professionals

5.5         Impact Analysis

6.           Branded Generics Market– North America Analysis

6.1         North America Branded Generics Market Revenue Forecast and Analysis

6.2         North America Branded Generics Market, By Country - Forecast and Analysis

7.           North America Branded Generics Market Revenue and Forecast To 2028– by Therapeutic Application

7.1         Overview

7.2         North America Branded Generics Market Revenue Share, By Therapeutic Application: Market Revenue and Forecast Analysis (US$ Billion)

7.3         Oncology

7.3.1        Overview

7.3.2        Oncology Market Revenue and Forecast to 2028 (US$ Billion)

7.4         Cardiovascular Diseases

7.4.1        Overview

7.4.2        Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.5         Diabetes

7.5.1        Overview

7.5.2        Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

7.6         Neurology

7.6.1        Overview

7.6.2        Neurology Market Revenue and Forecast to 2028 (US$ Billion)

7.7         Gastrointestinal Diseases

7.7.1        Overview

7.7.2        Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.8         Dermatology Diseases

7.8.1        Overview

7.8.2        Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

7.9         Analgesics and Anti-Inflammatory

7.9.1        Overview

7.9.2        Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

7.10      Others

7.10.1     Overview

7.10.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

8.           North America Branded Generics Market Analysis and Forecast to 2028 by Distribution Channel

8.1         North America Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

8.2         Hospital Pharmacies

8.2.1        Overview

8.2.2        Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.3         Retail Pharmacies

8.3.1        Overview

8.3.2        Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.4         Online Pharmacies

8.4.1        Overview

8.4.2        Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

8.5         Drug Stores

8.5.1        Overview

8.5.2        Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.           North America Branded Generics Market Analysis and Forecast to 2028 by Drug Class

9.1         North America Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

9.2         Alkylating Agents

9.2.1        Overview

9.2.2        Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.3         Antimetabolites

9.3.1        Overview

9.3.2        Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.4         Hormones

9.4.1        Overview

9.4.2        Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.5         Anti-hypertensive

9.5.1        Overview

9.5.2        Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.6         Lipid Lowering Drugs

9.6.1        Overview

9.6.2        Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.7         Anti-Depressants

9.7.1        Overview

9.7.2        Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.8         Anti-psychotics

9.8.1        Overview

9.8.2        Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.9         Anti-epileptic

9.9.1        Overview

9.9.2        Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

9.10      Others

9.10.1     Overview

9.10.2     Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

10.        North America Branded Generics Market Analysis and Forecast to 2028 – by Formulation Type

10.1      Overview

10.2      North America Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

10.3      Oral

10.3.1     Overview

10.3.2     Oral Market Revenue and Forecast to 2028 (US$ Billion)

10.4      Parenteral

10.4.1     Overview

10.4.2     Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

10.5      Topical

10.5.1     Overview

10.5.2     Topical Market Revenue and Forecast to 2028 (US$ Billion)

10.6      Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecast to 2028 (US$ Billion)

11.        North America Branded Generics Market Revenue and Forecasts to 2028 Country Analysis

11.1      Overview

11.1.1     North America: Branded Generics Market, by Country, 2022 & 2028 (%)

11.1.1.1       US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.1       Overview

11.1.1.1.2       US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.1.3       US: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.1.1.4       US: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.1.1.5       US: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.1.1.6       US: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.1.2       Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.1       Overview

11.1.1.2.2       Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.2.3       Canada: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.1.2.4       Canada: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.1.2.5       Canada: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.1.2.6       Canada: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

11.1.1.3       Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.1       Overview

11.1.1.3.2       Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

11.1.1.3.3       Mexico: Branded Generics Market, by Therapeutic Application, 2019–2028 (US$ Billion)

11.1.1.3.4       Mexico: Branded Generics Market, by Distribution Channel, 2019–2028 (US$ Billion)

11.1.1.3.5       Mexico: Branded Generics Market, by Drug Class, 2019–2028 (US$ Billion)

11.1.1.3.6       Mexico: Branded Generics Market, by Formulation Type, 2019–2028 (US$ Billion)

12.        Branded Generics Market–Industry Landscape

12.1      Overview

12.2      Growth Strategies Done by the Companies in the Market (%)

12.3      Organic Developments

12.3.1     Overview

12.4      Inorganic Developments

12.4.1     Overview

13.        Company Profiles

13.1      MYLAN N.V.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GlaxoSmithKline plc.

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Bausch Health Companies Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Lupin

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Sanofi

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      ASTRAZENECA PLC.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Dr. Reddy's Laboratories

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Par Pharmaceuticals, INC

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10   Sandoz International GMBH

13.10.1  Key Facts

13.10.2  Business Description

13.10.3  Products and Services

13.10.4  Financial Overview

13.10.5  SWOT Analysis

13.10.6  Key Developments

13.11   Aspen Holdings

13.11.1  Key Facts

13.11.2  Business Description

13.11.3  Products and Services

13.11.4  Financial Overview

13.11.5  SWOT Analysis

13.11.6  Key Developments

13.12   Hetero

13.12.1  Key Facts

13.12.2  Business Description

13.12.3  Products and Services

13.12.4  Financial Overview

13.12.5  SWOT Analysis

13.12.6  Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             US Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 2.             US Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 3.             US Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 4.             US Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 5.             Canada: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 6.             Canada Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 7.             Canada Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 8.             Canada Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 9.             Mexico: Branded Generics Market, by Therapeutic Application – Revenue and Forecast to 2028 (US$ Billion)

Table 10.          Mexico Branded Generics Market, by Distribution Channel– Revenue and Forecast to 2028 (US$ Billion)

Table 11.          Mexico Branded Generics Market, by Drug Class – Revenue and Forecast to 2028 (US$ Billion)

Table 12.          Mexico Branded Generics Market, by Formulation Type – Revenue and Forecast to 2028 (US$ Billion)

Table 13.          Organic Developments Done By Companies

Table 14.          Inorganic Developments Done By Companies

Table 15.          Glossary of Terms

LIST OF FIGURES

Figure 1.           North America Branded Generics Market Segmentation

Figure 2.           North America Branded Generics Market, By Country

Figure 3.           North America Branded Generics Market Overview

Figure 4.           Others Segment Held Largest Share of Drug Class Segment in North America Branded Generics Market

Figure 5.           Mexico is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           North America: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           Impact Analysis of Drivers and Restraints on North America Branded Generics Market

Figure 9.           North America Branded Generics Market – By Country Forecast and Analysis – 2019 - 2028

Figure 10.        North America Branded Generics Market Revenue Share, By Therapeutic Application: Market Analysis and Forecast 2022 and 2028 (%)

Figure 11.        North America Oncology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 12.        North America Cardiovascular Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 13.        North America Diabetes Market Revenue and Forecast to 2028 (US$ Billion)

Figure 14.        North America Neurology Market Revenue and Forecast to 2028 (US$ Billion)

Figure 15.        North America Gastrointestinal Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 16.        North America Dermatology Diseases Market Revenue and Forecast to 2028 (US$ Billion)

Figure 17.        North America Analgesics and Anti-Inflammatory Market Revenue and Forecast to 2028 (US$ Billion)

Figure 18.        North America Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 19.        North America Branded Generics Market Revenue Share, by Distribution Channel (2022 and 2028)

Figure 20.        North America Hospital Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 21.        North America Retail Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 22.        North America Online Pharmacies: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 23.        North America Drug Stores: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 24.        North America Branded Generics Market Revenue Share, by Drug Class (2022 and 2028)

Figure 25.        North America Alkylating Agents: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 26.        North America Antimetabolites: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 27.        North America Hormones: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 28.        North America Anti-hypertensive: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 29.        North America Lipid Lowering Drugs: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 30.        North America Anti-Depressants: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 31.        North America Anti-psychotics: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 32.        North America Anti-epileptic: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 33.        North America Others: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 34.        North America Branded Generics Market Revenue Share, by Formulation Type (2022 and 2028)

Figure 35.        North America Oral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 36.        North America Parenteral Market Revenue and Forecast to 2028 (US$ Billion)

Figure 37.        North America Topical Market Revenue and Forecast to 2028 (US$ Billion)

Figure 38.        North America Others Market Revenue and Forecast to 2028 (US$ Billion)

Figure 39.        North America: Branded Generics Market, by Key Country – Revenue (2022) (US$ Billion)

Figure 40.        North America: Branded Generics Market, by Country, 2022 & 2028 (%)

Figure 41.        US: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 42.        Canada: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 43.        Mexico: Branded Generics Market – Revenue and Forecast to 2028 (US$ Billion)

Figure 44.        Growth Strategies Done by the Companies in the Market (%)